NCT02177552 Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma Status UNKNOWN Phase PHASE2
NCT02176967 Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02175381 Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC Status COMPLETED Phase PHASE1/PHASE2
NCT02172846 Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02163694 A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer Status COMPLETED Phase PHASE3
NCT02161692 Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT02151149 Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Status COMPLETED Phase PHASE4
NCT02142738 Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) Status COMPLETED Phase PHASE3
NCT02137096 Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma Status TERMINATED Phase PHASE3
NCT02133625 A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02131064 A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT02130869 A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT02125344 A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) Status COMPLETED Phase PHASE3
NCT02124902 Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity Status TERMINATED Phase PHASE2
NCT02124707 Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN Status COMPLETED Phase PHASE2
NCT02124421 HOT: HIPEC in Ovarian Cancer as Initial Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02122770 Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02116959 Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma Status TERMINATED Phase PHASE1
NCT02114229 Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2